167
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Extremely low frequency (ELF) magnetic fields and apoptosis: a review

, , , &
Pages 1-11 | Received 26 Jul 2004, Accepted 29 Oct 2004, Published online: 03 Jul 2009

References

  • Abraham MC, Shaham S. 2004. Death without caspases, caspases without death. Trends in Cell Biology 14: 184–193.
  • Adams JM, Cory S. 1998. The Bc1-2 protein family: arbiters of cell survival. Science 281: 1322–1326.
  • Ahlbom IC, Cardis E, Green A, Linet M, Savitz D, Swerdlow A. 2001. Review of the epidemiologic literature on EMF and health. Environmental Health Perspectives 109: 911–933.
  • Algeciras-Schimnich A, Barnhart BC, Peter ME. 2002. Apoptosis-independent functions of killer caspases. Current Opinion in Cell Biology 14: 721–726.
  • Baureus Koch CLM, Sommarin M, Persson BR, R, Salfore LG, Eberhardt JL. 2003. Interaction between weak low frequency magnetic fields and cell membranes. Bioelectromagnetics 24: 395–402.
  • Bawin S, Adey W. 1976. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 73: 1999–2003.
  • Blackman CF, Benane SG, House DE. 2001. The influence of 1.2 microT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth. Bioelectromagnetics 22: 122–128.
  • Blanchard JP, Blackman CF. 1994. Clarification and application of an ion parametric resonance model for magnetic field interactions with biological systems. Bioelectromagnetics 15: 217–238.
  • Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. 2003. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22: 8608–8618.
  • Burlacu A. 2003. Regulation of apoptosis by Bc1-2 family proteins. Journal of Cellular and Molecular Medicine 7: 249–257.
  • Cecconi S, Gualtieri G, Di Bartolomeo A, Troiani G, Cifone MG, Canipari R. 2000. Evaluation of the effects of extremely low frequency electromagnetic fields on mammalian follicle devel-opment. Human Reproduction 15: 2319–2325.
  • Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM. 1997. Conversion of Bc1-2 to a Bax-like death effector by caspases. Science 278: 1966–1968.
  • Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. 2001. Bc1-2, Bc1-xl, sequester BH3 domain-only molecules preventing Bax- and Bak-mediated mitochon-drial apoptosis. Molecular Cell 8: 705–711.
  • Cohen II. 1996. Apoptosis and its regulation. Advances in Experimental Medicine and Biology 406: 11–20.
  • Craviso GL, Poss J, Lanctot C, Lundback SS, Chatterjee I, Publicover NG. 2002. Intracellular calcium activity in isolated bovine adrenal chromaffin cells in the presence and absence of 60 Hz magnetic fields. Bioelectromagnetics 23: 557–567.
  • Cristea IM, Degli Esposti M. 2004. Membrane lipids and cell death: an overview. Chemistry and Physics of Lipids 129: 133–160.
  • Cryns V, Yuan J. 1999. Proteases to die for. Genes and Development 13: 371–390.
  • Csordas G, Thomas AP, Hajnoczky G. 1999. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO Journal 18: 96–108.
  • Degterev A, Boyce M, Yuan J. 2003. A decade of caspases. Oncogene 22: 8543–8567.
  • Ding GR, Nakahara T, Tian FR, Guo Y, Miyakoshi J. 2001. Transient suppression of X-ray-induced apoptosis by exposure to power frequency magnetic fields in MCF-7 cells. Biochem-ical Biophysical Research Communications 286: 953–957.
  • Distelhorst CW, Shore GC. 2004. Bc1-2 and calcium: controversy beneath the surface. Oncogene 23: 2875–2880.
  • Dremina ES, Sharov VS, Kumar K, Zaidi A, Michaelis EK, Schoneich C. 2004. Antiapoptotic protein Bc1-2 interacts with and destabilizes the sarco/endoplasmic reticulum Ca-ATPase (SERCA). Biochemical Journal 383: 361–370.
  • El-Deiry WS. 1998. Regulation of p53 downstream genes. Seminars in Cancer Biology 8: 345–357.
  • Evan GI, Brown L, Whyte M, Harrington E. 1995. Apoptosis and the cell cycle. Current Opinions in Cell Biology 7: 825–834.
  • Fanelli C, Coppola S, Barone R, Colussi C, Gualandi G, Volpe P, Ghibelli L. 1999. Magnetic fields increase cell survival by inhibiting apoptosis via modulation of Ca2+ influx. FASEB Journal 13: 95–102.
  • Farrow SN, Brown R 1996. New members of the Bc1-2 family and their protein partners. Current Opinion in Genetics and Development 6: 45–49.
  • Fridman JS, Lowe SW. 2003. Control of apoptosis by p53. Oncogene 22: 9030–9040.
  • Gobba F, Malagoli D, Ottaviani E. 2003. Effects of 50 Hz magnetic fields on fMLP-induced shape changes in inverte-brate immunocytes: the role of calcium channels. Bioelectromagnetics 24: 277–282.
  • Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281: 1309–1312.
  • Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Epidemiology 11: 624–634.
  • Harland J, Engstrom S, Liburdy R. 1999. Evidence for a slow time-scale of interaction for magnetic fields inhibiting tamox-ifen's antiproliferative action in human breast cancer cells. Cell Biochemistry and Biophysics 31: 295–306.
  • Harland JD, Liburdy RP. 1997. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18: 555–562.
  • Harrington EA, Fanidi A, Evan GI. 1994. Oncogenes and cell death. Current Opinion in Gene Development 4: 120–129. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407: 770–776.
  • Hockenbery D, Oltvai Z, Yin XM, Milliman C, Korsmeyer SJ. 1993. Bc1-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241–251.
  • Hofseth LJ, Hussain SP, Harris CC. 2004. p53: 25 years after its discovery. Trends in Pharmacological Science 25: 177–181.
  • Ishido M, Nitta H, Kabuto M. 2001. Magnetic fields (MF) of 50 Hz at 1.2 microT as well as 100 microT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin la receptor in MF-sensitive MCF-7 cells. Carcinogenesis 22: 1043–1048.
  • Ismael SJ, Callera F, Garcia AB, Baffa 0, Falcao RP. 1998. Increased dexamethasone-induced apoptosis of thymocytes from mice exposed to long-term extremely low frequency magnetic fields. Bioelectromagnetics 19: 131–135.
  • jargensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proceedings of the National Academy of Sciences, USA 95: 4997–5002.
  • Kaiser F:. 1996. External signals and internal oscillation dynamics: biophysical aspects and modelling approaches for interactions of weak electromagnetic fields at the cellular level. Bioelec-trochemistry and Bioenergetics 41: 3–18.
  • Karbowski M, Youle RJ. 2003. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death and Differentiation 10: 870–880.
  • Kerr JF. 2002. History of the events leading to the formulation of the apoptosis concept. Toxicology 181–182: 471–474.
  • Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26: 239–257.
  • Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294–298.
  • Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RU, Distelhorst CW. 1994. Evidence that Bc1-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proceedings of the National Academy of Sciences, USA 91: 6569–6573.
  • Lednev VV. 1991. Possible mechanisms for the influence of weak magnetic fields on biological systems. Bioelectromagnetics 12: 71–75.
  • L,ee JS, Ahn SS, Jung KC, Kim YW, Lee SK. 2004. Effects of 60 Hz electromagnetic field exposure on testicular germ cell apoptosis in mice. Asian Journal of Anthology 6: 29–34.
  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.
  • Liboff AR, Cherng S, Jenrow KA, Bull A. 2003. Calmodulin-dependent cyclic nucleotide phosphodiesterase activity is altered by 20 microT magnetostatic fields. Bioelectromagnetics 24: 32–38.
  • Liburdy RP, Harland JD. 1997. Magnetic fields, melatonin, tamoxifen, and human breast cancer cell growth. In: Stevens RG, Wilson BW, Anderson LE, editors. The melatonin hypothesis - breast cancer and use of electric power. Columbus: Battelle. p. 669–700.
  • Lindstrom E, Lindstrom P, Berglund A, Lundgren E, Mild KH. 1995. Intracellular calcium oscillations in a T-cell line after exposure to extremely low frequency magnetic fields with variable frequencies and flux densities. Bioelectromagnetics 16: 41–47.
  • Mangiacasale R, Tritarelli A, Sciamanna I, Cannone M, Lavia P, Barberis MC, Lorenzini R, Cundari E. 2001. Normal and cancer-prone human cells respond differently to extremely low frequency magnetic fields. FEBS Letters 487: 397–403.
  • Martinou JC, Green DR. 2001. Breaking the mitochondrial barrier. Nature Reviews Molecular Cell Biology 2: 63–67.
  • McL,eod BR, Liboff AR 1986. Dynamic characteristics of membrane ions in multifield configurations of low frequency electromagnetic radiation. Bioelectromagnetics 7: 177–189.
  • Murray AW:. 2004. Recycling the cell cycle: cyclins revisited. Cell 116: 221–234.
  • Muschel RJ, McKenna WG. 1996. Alterations in cell cycle control during tumor progression: Effects on apoptosis and the response to therapeutic agents. Current Topics in Microbio-logical Immunology 213: 197–213.
  • Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. 2003. Degradation of chromosomal DNA during apoptosis. Cell Death and Differentiation 10: 108–116.
  • Nilsson JA, Cleveland JL. 2003. Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007–9021.
  • Olsson G, Belyaev IY, Helleday T, Harms-Ringdahl M. 2001. ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cells but does not interact with intrachromosomal recombination. Mutation Research 493: 55–66.
  • Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. 1996. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. Journal of Biological Chemistry 271: 16443–16446.
  • Panagopoulos DJ, Karabarbounis A, Margaritis LH. 2002. Mechanism for action of electromagnetic fields and cells. Biochemical and Biophysical Research Communications 298: 95–102.
  • Pelengaris S, Khan M. 2003. The many faces of c-MYC. Archives of Biochemistry and Biophysics 416: 129–136.
  • Pirozzoli MC, Marino C, Lovisolo GA, Laconi C, Mosiello L, Negroni A. 2003. Effects of 50 Hz electromagnetic field exposure on apoptosis and differentiation in a neuroblastoma cell line. Bioelectromagnetics 24: 510–516.
  • Prasad SC, Thraves PJ, Kuettel MR, Srinivasarao GY, Dritschilo A, Soldatenkov VA. 1998. Apoptosis-associated proteolysis of vimentin in human prostrate epithelial tumor cells. Biochem-ical and Biophysical Research Communications 249: 332–338.
  • Prendergast GC. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18: 2967–2987.
  • Reed JC:. 1998. Bc1-2 family proteins. Oncogene 17: 3225–3236.
  • Rheaume E, Cohen LY, Uhlmann F, Lazure C, Alam A, Hurwitz J, Sekaly RP, Denis F. 1997. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by caspase-3-like protease during Fas-mediated apoptosis. EMBO Journal 16: 6346–6354.
  • Rizzuto R, Brini M, Murgia M, Pozzan T. 1993. Microdomains with high Ca2+ close to 1P3-sensitive channels that are sensed by neighboring mitochondria. Science 262: 744–747.
  • Rizzuto R, Simpson AW, Brini M, Pozzan T. 1992. Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin. Nature 358: 325–327.
  • Robison JG, Pendleton AR, Monson KO, Murray BK, O'Neill KL. 2002. Decreased DNA repair rates and protection from heat induced apoptosis mediated by electromagnetic field exposure. Bioelectromagnetics 23: 106–112.
  • Ruchaud S, Korfali N, Villa P, Kottke TJ, Dingwall C, Kaufmann SH, Earnshaw WC. 2002. Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO Journal 21: 1967–1977.
  • Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, Clarke MF. 1994. C-myc and Bc1-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proceedings of the National Academy of Sciences, USA 91: 5878–5882.
  • Sax JK, El-Deiry WS. 2003. p53 downstream targets and chemosensitivity. Cell Death and Differentiation 10: 413–417.
  • Sharpe JC, Arnoult D, Youle RJ. 2004. Control of mitochondrial permeability by Bc1-2 family members. Biochimica et Biophy-sica Acta 1644: 107–113.
  • Sheikh MS, Huang Y. 2004. TRAIL death receptors, Bc1-2 protein family and endoplasmic reticulum calcium pool. Vitamins and Hormones 67: 169–188.
  • Shimizu S, Narita M, Tsujimoto Y. 1999. Bc1-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483–487.
  • Stevaux 0, Dyson NJ. 2002. A revised picture of the E2F transcriptional network and RB function. Current Opinion in Cell Biology 14: 684–691.
  • Swanton C. 2004. Cell-cycle targeted therapies. Lancet Oncology 5: 27–36.
  • Tantral L, Malathi K, Kohyama S, Silane M, Berenstein A, Jayaraman T. 2004. Intracellular calcium release is required for caspase-3 and -9 activation. Cell Biochemistry and Function 22: 35–40.
  • Teodori L, Grabarek J, Smolewski P, Ghibelli L, Bergamaschi A, De Nicola M, Darzynkiewicz Z. 2002. Exposure of cells to static magnetic field accelerates loss of integrity of plasma membrane during apoptosis. Cytometry 49: 113–118.
  • Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science 281: 1312–1316.
  • Tian F, Nakahara T, Yoshida M, Honda N, Hirose H, Miyakoshi J. 2002. Exposure to power frequency magnetic fields suppresses X-ray-induced apoptosis transiently in Ku80-deficient xrs5 cells. Biochemical Biophysical Research Com-munications 292: 355–361.
  • Tofani S, Barone D, Cintorino M, de Santi MM, Ferrara A, Orlassino R, Ossola P, Peroglio F, Rolfo K, Ronchetto F. 2001. Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics 22: 419–428.
  • Tsujimoto Y. 2003. Cell death regulation by the Bc1-2 protein family in the mitochondria. Journal of Cellular Physiology 195: 158–167.
  • Vaux DL. 2002. Apoptosis timeline. Cell Death and Differentia-tion 9: 349–354.
  • Verheyen GR, Pauwels G, Verschaeve L, Schoeters G. 2003. Effect of coexposure to 50 Hz magnetic fields and an aneugen on human lymphocytes, determined by the cytokinesis block micronucleus assay. Bioelectromagnetics 24: 160–164.
  • Vermeulen K, Berneman ZN, Van Bockstaele DR. 2003. Cell cycle and apoptosis. Cell Proliferation 36: 165–175.
  • Wang HG, Milian JA, Cox AD, Der CJ, Rapp UR, Beck T, Zha H, Reed JC. 1995. R-ras promotes apoptosis caused by growth factor deprivation via a Bc1-2 suppressible mechanism. Journal of Cell Biology 129: 1103–1114.
  • Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes and Development 14: 2060–2071.
  • Wen LP, Fahrni JA, Troie S, Guan JI,, Orth K, Rosen GD. 1997. Cleavage of focal adhesion kinase by caspase during apoptosis. Journal of Biological Chemistry 272: 26056–26061.
  • Wyllie AH. 1997. Apoptosis: an overview. British Medical Bulletin 53: 451–465.
  • Wyllie AH, Kerr JF, Currie AR. 1980. Cell death: the significance of apoptosis. International Review of Cytology 68: 251–305.
  • Zhou YP, Teng D, Dralyuk F, Ostrega D, Roe MW, Philipson L, Polonsky KS. 1998. Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. Journal of Clinical Investigations 101: 1623–1632.
  • Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochimica et Biophysica Acta 1241: 139–176.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.